BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18950568)

  • 1. [The controversial story of the human trypanolytic factor].
    Pays E; Vanhollebeke B
    Med Sci (Paris); 2008 Oct; 24(10):792-3. PubMed ID: 18950568
    [No Abstract]   [Full Text] [Related]  

  • 2. The trypanolytic factor of human serum.
    Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
    Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual self-defence: the trypanolytic factor story.
    Pays E; Vanhollebeke B
    Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The trypanolytic factor-mechanism, impacts and applications.
    Wheeler RJ
    Trends Parasitol; 2010 Sep; 26(9):457-64. PubMed ID: 20646962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum.
    Vanhollebeke B; Nielsen MJ; Watanabe Y; Truc P; Vanhamme L; Nakajima K; Moestrup SK; Pays E
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4118-23. PubMed ID: 17360487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
    Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
    Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection.
    Cuypers B; Lecordier L; Meehan CJ; Van den Broeck F; Imamura H; Büscher P; Dujardin JC; Laukens K; Schnaufer A; Dewar C; Lewis M; Balmer O; Azurago T; Kyei-Faried S; Ohene SA; Duah B; Homiah P; Mensah EK; Anleah F; Franco JR; Pays E; Deborggraeve S
    mBio; 2016 Apr; 7(2):e02198-15. PubMed ID: 27073096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular dialogue between African trypanosomes and humans].
    Pays E
    Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human innate immunity against African trypanosomes.
    Pays E; Vanhollebeke B
    Curr Opin Immunol; 2009 Oct; 21(5):493-8. PubMed ID: 19559585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human African trypanosomiasis: connecting parasite and host genetics.
    Garcia A; Courtin D; Solano P; Koffi M; Jamonneau V
    Trends Parasitol; 2006 Sep; 22(9):405-9. PubMed ID: 16837245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.
    Sternberg JM; Maclean L
    Parasitology; 2010 Dec; 137(14):2007-15. PubMed ID: 20663245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.
    Vanhollebeke B; Pays E
    Mol Microbiol; 2010 May; 76(4):806-14. PubMed ID: 20398209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Trypanosoma brucei gambiense resistance to human serum.
    Uzureau P; Uzureau S; Lecordier L; Fontaine F; Tebabi P; Homblé F; Grélard A; Zhendre V; Nolan DP; Lins L; Crowet JM; Pays A; Felu C; Poelvoorde P; Vanhollebeke B; Moestrup SK; Lyngsø J; Pedersen JS; Mottram JC; Dufourc EJ; Pérez-Morga D; Pays E
    Nature; 2013 Sep; 501(7467):430-4. PubMed ID: 23965626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus.
    Lecordier L; Uzureau P; Tebabi P; Brauner J; Benghiat FS; Vanhollebeke B; Pays E
    Mol Microbiol; 2015 Aug; 97(3):397-407. PubMed ID: 25899052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature of the trypanocidal factor in human serum.
    Seed JR; Sechelski JB
    J Parasitol; 1989 Dec; 75(6):1003-6. PubMed ID: 2614595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of resistance of African trypanosomes to cytotoxic human HDL.
    Hager KM; Hajduk SL
    Nature; 1997 Feb; 385(6619):823-6. PubMed ID: 9039915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposed density-dependent model of long slender to short stumpy transformation in the African trypanosomes.
    Seed JR; Black SJ
    J Parasitol; 1997 Aug; 83(4):656-62. PubMed ID: 9267408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African trypanosomes: intracellular trafficking of host defense molecules.
    Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
    J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human trypanolytic factor: a drug shaped naturally.
    Vanhamme L
    Infect Disord Drug Targets; 2010 Aug; 10(4):266-82. PubMed ID: 20429865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.